Influence of interferon-α treatment outcome in polycythemia vera and essential thrombocythemia by genetic polymorphism in IL28B
Journal of Hematological Malignancies · 2012
DOI: 10.5430/jhm.v2n3p18 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Hematological Malignancies, 2012. Verfasst von Marie Lindgren und 5 weiteren Autor:innen.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Lindgren, M., Pettersson, H., Westin, J., Lindh, M., Johansson, P., & Andreasson, B. (2012). Influence of interferon-α treatment outcome in polycythemia vera and essential thrombocythemia by genetic polymorphism in IL28B. Journal of Hematological Malignancies. https://doi.org/10.5430/jhm.v2n3p18
Vancouver
Lindgren M, Pettersson H, Westin J, Lindh M, Johansson P, Andreasson B. Influence of interferon-α treatment outcome in polycythemia vera and essential thrombocythemia by genetic polymorphism in IL28B. Journal of Hematological Malignancies. 2012. doi:10.5430/jhm.v2n3p18
BibTeX
@article{Lindgren2012,
author = {Lindgren, Marie and Pettersson, Helna and Westin, Johan and Lindh, Magnus and Johansson, Peter and Andreasson, Björn},
title = {Influence of interferon-α treatment outcome in polycythemia vera and essential thrombocythemia by genetic polymorphism in IL28B},
journal = {Journal of Hematological Malignancies},
year = {2012},
doi = {10.5430/jhm.v2n3p18}
}
EUVIMED